BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PsychU - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PsychU
X-ORIGINAL-URL:https://psychu.org
X-WR-CALDESC:Events for PsychU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20241113T080000
DTEND;TZID=America/Los_Angeles:20241116T190000
DTSTAMP:20261108T002228
CREATED:20241101T164932Z
LAST-MODIFIED:20241101T164937Z
UID:10004143-1731484800-1731783600@psychu.org
SUMMARY:GSA 2024 Annual Scientific Meeting
DESCRIPTION:Home\n							\n							\n						\n				\n			\n\n\n\n\n        About This Event\n        \n            \n                \n            \n            \n                \n            \n        \n    \n        \n            ADHD Neurobiology: Exploring Dopamine\, Norepinephrine\, & Serotonin in an Integrative Model\n            Join us in Seattle\, WA to collaborate & network with colleagues and discover the newest innovations in research\, clinical practice\, and education across the diverse array of disciplines that come together under gerontology’s wide scope\, from biosciences and psychology to policy and industry. With a large variety of scientific sessions\, as well as posters\, award-winning lecturers and other featured speakers\, you’re guaranteed to learn about the latest cutting-edge scholarship and innovations in your own specialty\, and gain valuable new insights into what’s happening across the spectrum of aging research. \n        \n\n\n\nEvent Link\n\n\n\n\n\n\n\n\n					\n						Related Resources\n						\n							\n								\n							\n							\n								\n							\n						\n					\n					\n						\n							\n							 \n						\n						\n						\n						\n							\n							\n								\n							\n							 ADHD Neurobiology: Exploring Dopamine\, Norepinephrine\, & Serotonin in an Integrative Model\n							\n								On-Demand Webinar October 28\, 2026\n							\n							In this PsychU webinar\, Stephen V. Faraone\, PhD\, Distinguished Professor of Psychiatry and of Neuroscience and Physiology at SUNY Upstate Medical University\, and examines the evolving understanding of attention-deficit/hyperactivity disorder… \n						\n							\n							 Executive Dysfunction & Emotional Dysregulation in ADHD\n							\n								On-Demand Webinar August 13\, 2026\n							\n							In this PsychU webinar\, Stephen V. Faraone\, PhD\, Distinguished Professor of Psychiatry and of Neuroscience and Physiology at SUNY Upstate Medical University\, and examines the evolving understanding of attention-deficit/hyperactivity disorder… \n						\n							\n							 Executive Dysfunction & Emotional Dysregulation In ADHD\n							\n								Infographic August 11\, 2026\n							\n							An infographic highlighting the ADHD Neurobiology : The Interplay Between Dopamine\, Norepinephrine\, And Serotonin
URL:https://psychu.org/event/gsa-2024-annual-scientific-meeting/
CATEGORIES:Supporter Event
ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/11/GSA-logo-CMYK.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T120000
DTEND;TZID=America/New_York:20241114T130000
DTSTAMP:20261108T002228
CREATED:20240926T210905Z
LAST-MODIFIED:20240927T132642Z
UID:10004128-1731585600-1731589200@psychu.org
SUMMARY:Treatment Pathways Across Cultures
DESCRIPTION:Home\n							\n							\n						\n				\n			\n\n\n\n\n\n\n	\n	\n	\n	\n	\n	\n\n	\n	\n	\n\n	\n	\n	\n	\n	\n	\n\n	\n\n\n\n	\n	\n	\n	\n	\n	\n	\n	\n\n\n\n            \n                Thank You For Attending Today’s Webinar\n                Please tell us what you thought about today’s presentation by taking the survey below: \n            \n             \n        \n\n\n        About This Event\n        \n            \n                \n            \n            \n                \n            \n        \n    \n        \n            ADHD Neurobiology: Exploring Dopamine\, Norepinephrine\, & Serotonin in an Integrative Model\n            Understanding the cultural aspects of treating bipolar disease offers invaluable insights into how diverse ethnic backgrounds influence the perception\, diagnosis and the management of this condition. Appreciating these differences can improve communication between healthcare providers and patients and lead to more improved\, personalized and effective healthcare treatment plans. During this webinar\, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact of culture across treatment pathways for bipolar disorder\, and how cultural context can be integrated into treatment strategies for this condition. \n        \n\n\n\n\n\n\n            \n                Featuring\n            \n        \n\n\n            \n                \n            \n            \n                Michael Aldape\, PhD\n                Senior Medical Science Liaison \n                \n            \n        \n\n\n            \n                \n            \n            \n                Crystal T. Clark\, MD\, MSc\n                Associate Professor\, Department of Psychiatry\, University of Toronto; Research Investigator\, Associate Head of Research\, Department of Psychiatry\, Women’s College Hospital (Toronto\, Ontario) \n                \n            \n            More\n            \n            Dr. Clark is an Associate Professor in the Department of Psychiatry at the University of Toronto. She is also a scientist at Women’s College Research Institute and will serve as the Associate Head of Research at the Women’s College Hospital. Dr. Clark is a past president of the Marcé of North America and serves on the board of directors of Marcé International. She received her Bachelor of Arts in Psychology from Northwestern University and her Master of Science and Medical Doctorate from the University of Louisville\, Kentucky (2006). She completed her adult psychiatry training and served as chief resident at Johns Hopkins in Baltimore\, Maryland\, USA (2010). Prior to completing her MSc in Clinical Investigation Sciences (2012)\, she completed fellowship training in clinical research and reproductive psychiatry while also serving on faculty at the Baylor College of Medicine/Michael E. Debakey VA as well as the University of Pittsburgh Medical Center/ Pittsburgh VA Healthcare Systems. Prior to joining UofT\, she served as an Associate Professor at Northwestern University\, Chicago. There she was a Staff Psychiatrist at the Northwestern Memorial Hospital; and Clinical Director of the Women’s Outpatient Program\, Asher Center for the Study and Treatment of Depressive Disorders. She also co-founded and co-directed and advanced training fellowship in women’s and reproductive mental health.\n            \n        \n\n\n            \n                \n            \n            \n                Mauricio Tohen\, MD\, DrPH\, MBA\n                Chairman\, Department of Psychiatry and Behavioral Sciences\, Distinguished University Professor\, University of New Mexico\n \n                \n            \n            More\n            \n            Mauricio Tohen\, MD\, DrPH\, MBA\, is a University Distinguished Professor and Chairman of the Department of Psychiatry at the University of New Mexico Health Science Center\, Albuquerque NM. From 2009 to 2013 he was a Professor of Psychiatry and The Krus Endowed Chair in Psychiatry at the University of Texas Health Science Center at San Antonio. Dr. Tohen received his medical degree from the National University of Mexico and his Doctor of Public Health degree in Epidemiology from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto\, a clinical fellowship at McLean Hospital and Harvard Medical School\, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. From 1988 to 1997\, Dr. Tohen was the Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he was a member of Lilly Research Laboratories reaching the senior-most scientific level of Distinguished Lilly Scholar. In 2009 he joined the University of Texas Health Science Center at San Antonio as the Head of the Division of Mood and Anxiety Disorders. Dr. Tohen received a National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University. He also received a FIRST award from the NIMH\, the Pope Award from McLean Hospital\, and a NARSAD Young Investigator Award and the Simon Bolivar Award from the American Psychiatric Association. In 2014 he was named by Thomson Reuter’s “The World’s Most Influential Scientific Minds\, 2014”. Honorees were the scientists who ranked in the Top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012.\n            \n        \n\n\nDr. Michael Aldape\, PhD\, Dr. Mauricio Tohen\, MD\, DrPH\, MBA and Dr. Crystal Clark\, MD\, MSc are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. \n\n\n\n				Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)\, Otsuka America Pharmaceutical\, Inc. (OAPI)\, and Lundbeck\, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as\, nor is it a substitute for\, medical care\, advice\, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC\, OAPI\, and / or Lundbeck\, LLC.  \n				September 2024    US.CORP.X.24.00280\n			\n\n\n\n\n\n\n\n\n\n\n	\n	Registration\n	\n	\n	\n	\n	\n	\n\n\n\n\n\n\n\n\n\n\n					\n						Related Resources\n						\n							\n								\n							\n							\n								\n							\n						\n					\n					\n						\n							\n							 \n						\n						\n						\n						\n							\n							\n								\n							\n							 ADHD Neurobiology: Exploring Dopamine\, Norepinephrine\, & Serotonin in an Integrative Model\n							\n								On-Demand Webinar October 28\, 2026\n							\n							In this PsychU webinar\, Stephen V. Faraone\, PhD\, Distinguished Professor of Psychiatry and of Neuroscience and Physiology at SUNY Upstate Medical University\, and examines the evolving understanding of attention-deficit/hyperactivity disorder… \n						\n							\n							 Executive Dysfunction & Emotional Dysregulation in ADHD\n							\n								On-Demand Webinar August 13\, 2026\n							\n							In this PsychU webinar\, Stephen V. Faraone\, PhD\, Distinguished Professor of Psychiatry and of Neuroscience and Physiology at SUNY Upstate Medical University\, and examines the evolving understanding of attention-deficit/hyperactivity disorder… \n						\n							\n							 Executive Dysfunction & Emotional Dysregulation In ADHD\n							\n								Infographic August 11\, 2026\n							\n							An infographic highlighting the ADHD Neurobiology : The Interplay Between Dopamine\, Norepinephrine\, And Serotonin
URL:https://psychu.org/event/treatment-pathways-across-cultures/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://psychu.org/wp-content/uploads/2022/05/Bipolar_LAI_912x506_shutterstock_1997810351.png
END:VEVENT
END:VCALENDAR